Newsletter

237690 - ST Pharm Co., Ltd.

237690 Summary
Biopharma
Stock Price & Overview
₩91,000 -900 (-0.98%) Close · Sep 9, 2026 KST
KOSDAQ | ₩KRW | Close: ₩91,000  ≈ US$65  ·  Market cap ₩1.9tn (≈ $1.4bn)
Home › 237690 › Filings

Investor Relations Event

DART
ST Pharm Co., Ltd.
Filed Sep 9, 2026 KST · IR · receipt 20260909900395

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 기업설명회(IR)개최

237690

Price
₩91,000
Change
-0.98%
Market cap
₩1.9tn
Prev. close
₩91,900
237690 SummaryCompare to Peers

237690 data on kstock

Financials
11 fiscal years

Every figure is taken from ST Pharm Co., Ltd.'s own DART filings and matched on IFRS account codes, so a line holds across years where the Korean wording changed.

More 237690 filings

Half-Year Report

08/14/26

Convertible bonds bought back before maturity

08/11/26

Insider / Major Shareholder Holdings Report

07/31/26

Investor Relations Event

07/27/26

Preliminary Consolidated Results (Fair Disclosure)

07/27/26

Investor Relations Event

07/23/26
All 237690 filings